project id: TCGA-UCEC; case submitter id: TCGA-AX-A3GB; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 7.1; age at index: 73; days to birth: -26724; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 26724; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 440.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 469; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: b473b052-e1f3-40d2-bf32-7873263973c9; sample submitter id: TCGA-AX-A3GB-01A; portion id: 4a34ae7c-2422-4008-92e9-1a1d90c4dc29; portion submitter id: TCGA-AX-A3GB-01A-11; slide id: c4ecaa83-86a6-478c-8a8a-977cbdf9755f; slide submitter id: TCGA-AX-A3GB-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 78.0; percent tumor nuclei: 90.0; section location: TOP;